PLYMOUTH MEETING, Pa., Nov. 11, 2026 /PRNewswire/ — INOVIO (NASDAQ: INO), a commercial-stage biotechnology company focused on developing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following investor conferences: Jefferies Global Healthcare Conference in LondonDate: Wednesday, November 18Time: 12:00 p.m. … Continue reading "INOVIO to Par…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.